Finance

Lists
Why is VVOS down 5.10%?
Dive Deeper
VVOS:NASDAQ
Vivos Therapeutics Inc
$0.054
-5.10%
(-0.0029) 1D
$0.052
-3.70% (-0.0020)
After hours
Closed: Nov 20, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VVOS...
Open
$0.05
High
$0.06
Low
$0.05
Mkt. cap
1.73M
Avg. vol.
5.96M
Volume
1.44M
52-wk high
$2.69
52-wk low
$0.05
EPS
-$1.88
Beta
6.37
Shares outstanding
33.82M
No. of employees
270
Open
$0.05
High
$0.06
Low
$0.05
Mkt. cap
1.73M
Avg. vol.
5.96M
Volume
1.44M
52-wk high
$2.69
52-wk low
$0.05
EPS
-$1.88
Beta
6.37
Shares outstanding
33.82M
No. of employees
270
News stories
From web sources and news partners
About Vivos Therapeutics Inc
CEO-
Employees270
Founded2016
HeadquartersLittleton, Colorado, United States
SectorHealth Care
IndustryHealth care provider
Websitevivos.com
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Henry
Alliance Global Partners
Hold
Maintained
$0.75
+1,288.9%
07/08/2026
Lucas Ward
Ascendiant
Buy
Reiterated
$3.10
+5,640.7%
06/04/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$2.50
+4,529.6%
04/17/2026
Unknown Analyst
Alliance Global Partners
Hold
Maintained
$2.50
+4,529.6%
01/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.82M
5.14M
5.15M
6.41M
Cost of goods sold
836.00K
2.08M
2.20M
3.10M
Cost of revenue
836.00K
2.08M
2.20M
3.10M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.93M
9.22M
7.27M
6.66M
Operating expense
9.37M
9.67M
7.78M
7.21M
Total operating expenses
10.21M
11.76M
9.98M
10.31M
Operating income
-6.38M
-6.62M
-4.82M
-3.90M
Other non operating income
-572.00K
-1.14M
102.00K
1.92M
EBT including unusual items
-6.95M
-7.75M
-5.52M
-1.97M
EBT excluding unusual items
-6.95M
-7.75M
-5.82M
-1.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.89M
-7.68M
-5.48M
-1.94M
Net profit margin
-180.28%
-149.43%
-106.37%
-30.32%
Earnings per share
-0.58
-0.52
-0.31
-0.07
Interest and investment income
-
-
-
-
Interest expense
-
-
-1.10M
-
Net interest expenses
-
-
-1.10M
-
Depreciation and amortization charges
442.00K
454.00K
510.00K
550.00K
EBITDA
-5.94M
-6.16M
-4.31M
-3.35M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps